Brazilian pharmaceutical manufacturer with in-house R&D and nutraceutical subsidiary
Althaia manufactures pharmaceuticals and nutraceuticals in Brazil with an on-site research center where all products originate. The hiring mix is heavily weighted toward sales (19 roles) and manufacturing (17 roles) relative to R&D (8 roles), reflecting a commercial execution phase focused on market penetration rather than pipeline expansion. Active projects span dosing method validation, new product development, and pharmacy staff training—typical patterns for a mid-market manufacturer scaling distribution.
Althaia S.A. is a privately held pharmaceutical manufacturer founded in 2010, based in Atibaia, São Paulo. The company develops, manufactures, and distributes modern medicines under the Althaia brand and nutritional supplements through its Equaliv subsidiary. Operations include a dedicated R&D center at headquarters, validated manufacturing processes (HPLC, SAP, WMS, PLC systems), and direct-to-pharmacy and retail channels. The organization operates across Brazil with 501–1,000 employees and maintains quality and regulatory standards across both pharmaceutical and nutraceutical product lines.
SAP for enterprise resource planning, WMS for warehouse management, PLC systems for production automation, HPLC for analytical testing, Minitab and JMP for quality control, and Active Directory for IT infrastructure.
Yes. The company operates a dedicated research and development center at its headquarters where product development occurs, with 8 active R&D roles and ongoing projects in dosing method development and new product formulation.
Other companies in the same industry, closest in size